panglobal | Clinlabint

FairJourney Biologics establishes Supervisory Board to accelerate antibody discovery innovation

22 April 2025 in E-News /by panglobal

FairJourney Biologics S.A., a global leader in antibody discovery and development based in Porto, Portugal, has announced the formation of a new Supervisory Board aimed at enhancing the company’s strategic positioning and accelerating innovation in antibody research. The board, comprising distinguished industry veterans with extensive expertise in biopharmaceutical development, will focus on defining key growth […]

DayOne Accelerator relaunches to bridge healthtech innovation gap with pharma industry

22 April 2025 in E-News /by panglobal

The equity-free accelerator programme, based in Basel’s life sciences hub, aims to address the 80% failure rate of healthtech startups by providing direct access to pharmaceutical expertise and resources.

German clinical diagnostics leader partners with US genomics innovator to advance cancer testing

22 April 2025 in E-News /by panglobal

Cancer diagnostics in Germany is set to enter a new phase as Labor Dr. Wisplinghoff collaborates with US-based Genomic Testing Cooperative to implement advanced molecular testing capabilities, with RNA analysis at the forefront of this precision medicine initiative.

Navigo Proteins and SCK CEN join forces to advance targeted radiotheranostics

22 April 2025 in E-News /by panglobal

German biotechnology company Navigo Proteins has established a strategic research collaboration with SCK CEN, the Belgian Nuclear Research Centre, to accelerate development of targeted radiotheranostics. The partnership aims to combine Navigo’s expertise in precision carrier molecules with SCK CEN’s capabilities in radioisotope production and preclinical testing.

Wiley expands forensic capabilities with updated designer drugs database

22 April 2025 in E-News, Therapeutic Drug Monitoring /by panglobal

Wiley has announced the release of its 2025 edition of the Mass Spectra of Designer Drugs database, a critical resource expanding forensic laboratories’ capabilities in the identification of illicit substances. The updated database represents a substantial advancement in analytical tools available to forensic scientists combating the proliferation of novel psychoactive substances.

Alarming rise in child deaths from antimicrobial resistance

15 April 2025 in E-News /by panglobal

New research reveals over 3 million children died globally from AMR-related infections in 2022, with particular concerns about increasing use of critical antibiotic classes.

IL-6 biomarker breakthrough for early sepsis detection

15 April 2025 in E-News, Molecular Diagnostics /by panglobal

New research identifies interleukin-6 as a superior diagnostic biomarker for sepsis in high-risk populations including neonates, children, and pregnant women.

Pfizer halts development of oral GLP-1 agonist danuglipron

15 April 2025 in E-News /by panglobal

Safety concerns prompt Pfizer to terminate development of once-daily oral GLP-1 receptor agonist for weight management, despite promising pharmacokinetic data from recent dose-optimisation studies.

Basel-based equity-free DayOne Accelerator opens for healthtech startups

14 April 2025 in E-News /by panglobal

Basel’s equity-free pharma-focused accelerator programme returns to bridge the gap between healthtech innovations and pharmaceutical R&D needs.

Bruker expands infectious disease diagnostics portfolio at ESCMID 2025

12 April 2025 in Product News /by panglobal

Bruker Corporation has announced significant expansions to its infectious disease testing solutions at the ESCMID Global conference in Vienna, including a broader assay menu for its BeGenius® molecular diagnostics system and improvements to its microbial identification platforms.

About panglobal

Entries by panglobal

FairJourney Biologics establishes Supervisory Board to accelerate antibody discovery innovation

DayOne Accelerator relaunches to bridge healthtech innovation gap with pharma industry

German clinical diagnostics leader partners with US genomics innovator to advance cancer testing

Navigo Proteins and SCK CEN join forces to advance targeted radiotheranostics

Wiley expands forensic capabilities with updated designer drugs database

Alarming rise in child deaths from antimicrobial resistance

IL-6 biomarker breakthrough for early sepsis detection

Pfizer halts development of oral GLP-1 agonist danuglipron

Basel-based equity-free DayOne Accelerator opens for healthtech startups

Bruker expands infectious disease diagnostics portfolio at ESCMID 2025

Latest issue of Clinical laboratory

New Chromsystems Product for Antiepileptic Drugs Testing

Trusted analytical solutions for reliable results

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Free subscription

Get our e-alert

Author Archive for: panglobal

About panglobal

Entries by panglobal

Latest issue of Clinical laboratory

Free subscription

Get our e-alert